Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure

Inflammation

Volumn 36, Issue 1, 2013, Pages 110-120

  Cao, Dayan ^a   Xu, Huan ^a   Guo, Guoning ^a   Ruan, Zhihua ^a   Fei, Lei ^a   Xie, Zhunyi ^a   Wu, Yuzhang ^a   Chen, Yongwen ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

FGL2; immunohistochemistry; PD 1; PD L1; PD L2

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CYTOKERATIN 18; FIBRINOGEN LIKE PROTEIN 2; PROCOAGULANT; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROGRAMMED DEATH 1 RECEPTOR; UNCLASSIFIED DRUG;

ACUTE ON CHRONIC LIVER FAILURE; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER PARENCHYMA; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; PATHOGENESIS; PROTEIN EXPRESSION;

ANTIGENS, CD274; APOPTOSIS; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; END STAGE LIVER DISEASE; EPITHELIAL CELLS; FIBRINOGEN; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; KILLER CELLS, NATURAL; LIGANDS; LIVER; LIVER FAILURE, ACUTE; MACROPHAGES; MONOCYTES; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; PROGRAMMED CELL DEATH 1 RECEPTOR; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 84872932013     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9525-7     Document Type: Article

References (32)

1. Stravitz, R.T., and D.J. Kramer. 2009. Management of acute liver failure. Nature Reviews. Gastroenterology & Hepatology 6: 542-553.
2. Marsden, P.A., Q. Ning, L.S. Fung, X. Luo, Y. Chen, M. Mendicino, A. Ghanekar, J.A. Scott, T. Miller, C.W. Chan, M.W. Chan, W. He, R.M. Gorczynski, D.R. Grant, D.A. Clark, M.J. Phillips, and G.A. Levy. 2003. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. The Journal of Clinical Investigation 112: 58-66. (Pubitemid 38056376)
3. Liu, Q., Z. Liu, T. Wang, Q. Wang, X. Shi, and W. Dao. 2007. Characteristics of acute and sub-Acute liver failure in China: nomination, classification and interval. Journal of Gastroenterology and Hepatology 22: 2101-2106. (Pubitemid 350145590)
4. Liu, M., C.W. Chan, I. McGilvray, Q. Ning, and G.A. Levy. 2001. Fulminant viral hepatitis: molecular and cellular basis, and clinical implications. Expert Reviews in Molecular Medicine 2001: 1-19.
5. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141-151. (Pubitemid 29428807)
6. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Medicine 5: 1365-1369.
7. Latchman, Y., C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A.J. Long, J.A. Brown, R. Nunes, E.A. Greenfield, K. Bourque, V.A. Boussiotis, L.L. Carter, B.M. Carreno, N. Malenkovich, H. Nishimura, T. Okazaki, T. Honjo, A.H. Sharpe, and G.J. Freeman. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nature Immunology 2: 261-268. (Pubitemid 33706004)
8. Nishimura, H., T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hiai, N. Minato, and T. Honjo. 2001. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291: 319-322. (Pubitemid 32096320)
9. Okazaki, T., Y. Tanaka, R. Nishio, T. Mitsuiye, A. Mizoguchi, J. Wang, M. Ishida, H. Hiai, A. Matsumori, N. Minato, and T. Honjo. 2003. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nature Medicine 9: 1477-1483. (Pubitemid 38004774)
10. Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology 26: 677-704. (Pubitemid 351600389)
11. Iwai, Y., S. Terawaki, M. Ikegawa, T. Okazaki, and T. Honjo. 2003. PD-1 inhibits antiviral immunity at the effector phase in the liver. The Journal of Experimental Medicine 198: 39-50. (Pubitemid 36870184)
12. Jun, H., S.K. Seo, H.Y. Jeong, H.M. Seo, G. Zhu, L. Chen, and I.H. Choi. 2005. B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK). FEBS Letters 579: 6259-6264. (Pubitemid 41546277)
13. Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687. (Pubitemid 43237609)
14. Zhang, Z., J.Y. Zhang, E.J. Wherry, B. Jin, B. Xu, Z.S. Zou, S.Y. Zhang, B.S. Li, H.F. Wang, H. Wu, G.K. Lau, Y.X. Fu, and F.S. Wang. 2008. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134: 1938-1949. (Pubitemid 351783271)
15. Evans, A., A. Riva, H. Cooksley, S. Phillips, S. Puranik, A. Nathwani, S. Brett, S. Chokshi, and N.V. Naoumov. 2008. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-Antigen seroconversion. Hepatology 48: 759-769.
16. Xie, Z., Y. Chen, S. Zhao, Z. Yang, X. Yao, S. Guo, C. Yang, L. Fei, X. Zeng, B. Ni, and Y. Wu. 2009. Intrahepatic PD-1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection. Immunological Investigations 38: 624-638.
17. Chen, Y., S. Wu, G. Guo, L. Fei, S. Guo, C. Yang, X. Fu, and Y. Wu. 2011. Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection. PLoS Pathogens 7: e1001347.
18. Li H, Wang C, Guo G, Gao C, Wu Y, Chen Y. 2012. The characteristic expression of B7-Associated proteins in Langerhans cell sarcoma. Acta Histochemica 114:733-743.
19. Jin, H.T., R. Ahmed, and T. Okazaki. 2011. Role of PD-1 in regulating T-cell immunity. Current Topics in Microbiology and Immunology 350: 17-37.
20. Francisco, L.M., P.T. Sage, and A.H. Sharpe. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunology Reviews 236: 219-242.
21. Shin, T., G. Kennedy, K. Gorski, H. Tsuchiya, H. Koseki, M. Azuma, H. Yagita, L. Chen, J. Powell, D. Pardoll, and F. Housseau. 2003. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. The Journal of Experimental Medicine 198: 31-38. (Pubitemid 36870183)
22. Tseng, S.Y., M. Otsuji, K. Gorski, X. Huang, J.E. Slansky, S.I. Pai, A. Shalabi, T. Shin, D.M. Pardoll, and H. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. The Journal of Experimental Medicine 193: 839-846. (Pubitemid 32524533)
23. Dong, H., S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, P.C. Roche, J. Lu, G. Zhu, K. Tamada, V.A. Lennon, E. Celis, and L. Chen. 2002. Tumor-Associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nature Medicine 8: 793-800.
24. Singh, A.K., P. Stock, and O. Akbari. 2011. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 66: 155-162.
25. Watanabe, T., A. Bertoletti, and T.A. Tanoto. 2010. PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection. Journal of Viral Hepatitis 17: 453-458.
26. del Rio, M.L., L. Buhler, C. Gibbons, J. Tian, and J.I. Rodriguez-Barbosa. 2008. PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transplant International 21: 1015-1028.
27. Ma, S.W., X. Huang, Y.Y. Li, L.B. Tang, X.F. Sun, X.T. Jiang, Y.X. Zhang, J. Sun, Z.H. Liu, W.G. Abbott, Y.H. Dong, N.V. Naoumov, and J.L. Hou. 2012. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. Journal of Hepatology 56: 775-781.
28. Raziorrouh, B., W. Schraut, T. Gerlach, D. Nowack, N.H. Grüner, A. Ulsenheimer, R. Zachoval, M. Wächtler, M. Spannagl, J. Haas, H.M. Diepolder, and M.C. Jung. 2010. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 52: 1934-1947.
29. Loke, P., and J.P. Allison. 2003. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proceedings of the National Academy of Sciences of the United States of America 100(9): 5336-5341. (Pubitemid 36542706)
30. Ding, J.W., Q. Ning, M.F. Liu, A. Lai, J. Leibowitz, K.M. Peltekian, E.H. Cole, L.S. Fung, C. Holloway, P.A. Marsden, H. Yeger, M.J. Phillips, and G.A. Levy. 1997. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. Journal of Virology 71: 9223-9230. (Pubitemid 27492364)
31. Li, C., L.S. Fung, S. Chung, A. Crow, N. Myers-Mason, M.J. Phillips, J.L. Leibowitz, E. Cole, C.A. Ottaway, and G. Levy. 1992. Monoclonal anti-prothrombinase (3D4.3) prevents mortality from murine hepatitis virus infection (MHV-3). The Journal of Experimental Medicine 176: 689-697.
32. Qin, X.H., V.W. Lee, Y.P. Wang, G.P. Zheng, Y. Wang, S.I. Alexander, and D.C. Harris. 2006. A protective role for programmed death 1 in progression of murine adriamycin nephropathy. Kidney International 70: 1244-1250. (Pubitemid 44435175)